EUVIMEDOpdag EUVIMED
Crossref

Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator

Marie Skov Breum iD, Mads Sundby Palle

Statistics in Medicine · 2025

DOI: 10.1002/sim.70305 ↗

At a glance

Journal article in Statistics in Medicine, 2025. Written by Marie Skov Breum and 1 co-authors. Institution: Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Major MEDLINE topics: Randomized Controlled Trials as Topic, Mediation Analysis. 39 references. Funded by: Novo Nordisk.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Causal mediation analysis is an important tool in medical research, enabling researchers to examine and quantify the mechanisms through which a treatment exerts its effects on an outcome of interest. In many studies, the potential mediator is measured repeatedly over time, and we expect feedback between other post‐treatment covariates and the mediator. Randomized interventional (also called stochastic) effects have been proposed for defining causal mediation estimands in longitudinal settings, because they are identifiable in the presence of post‐treatment mediator‐outcome confounders. In this article, we use the interventional effects framework to investigate the mediating pathways in a clinical trial that compared the effect of semaglutide versus placebo on the histological resolution of nonalcoholic steatohepatitis (NASH). We define and identify various interventional direct and indirect effects relevant to the research question. For estimation, we propose an efficient and multiply robust Targeted Minimum Loss Estimator (TMLE), and we showcase the theoretical properties of the estimator in a simulation study.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicMediation AnalysisHumansNon-alcoholic Fatty Liver DiseaseComputer SimulationGlucagon-Like PeptidesModels, StatisticalTreatment OutcomeCausalityGlucagon-Like Peptide 1Semaglutide

Author keywords

TMLEcausal inferencelongitudinal datamediation analysis

Substances

Glucagon-Like PeptidesGlucagon-Like Peptide 1Semaglutide

Authors and institutions

  • Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Novo Nordisk A/S, Bagsværd, Denmark.

ORCID profiles: Marie Skov Breum

Funding

  • Novo Nordisk

Cite

APA

Skov Breum, M., & Sundby Palle, M. (2025). Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator. Statistics in Medicine. https://doi.org/10.1002/sim.70305

Vancouver

Skov Breum M, Sundby Palle M. Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator. Statistics in Medicine. 2025. doi:10.1002/sim.70305

BibTeX
@article{SkovBreum2025,
  author = {Skov Breum, Marie and Sundby Palle, Mads},
  title = {Estimation of Interventional Effects in Clinical Trials With a Repeatedly Measured Mediator},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70305}
}
Start for free →